Advancing Subcutaneous Oncology: Building System Readiness Across Healthcare | May 28, 2026

As cancer systems face mounting pressures, including growing treatment volumes, workforce constraints, and limited infusion capacity, new delivery models are increasingly being explored to support more efficient, patient‑centred care. Subcutaneous oncology therapies represent one such care delivery innovation, with potential implications for patient experience, clinical workflows, and health‑system capacity.This session will examine subcutaneous administration from a system readiness and implementation standpoint, focusing on the practical considerations required to integrate new delivery models into routine cancer care. Discussion will centre on operational realities such as clinic workflows, pharmacy preparation, nursing time, protocol development, and institutional planning.Overall, the session aims to foster a balanced, evidence‑informed discussion on how health systems can prepare for and safely implement Sub‑Q oncology therapies, with a focus on feasibility, operational impact, and patient experience, while improving health system capacity.*The views expressed on the Economic Club of Canada platform are not that of the Economic Club or its affiliates but of the speakers alone and the organizations they represent.*